Voyager Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Lexington, MA
VYGR chart
What traders are saying about $VYGR
Latest postsVoyager Therapeutics, Inc. news
- Voyager Therapeutics stock trades at 1.76 euros Tuesday
ad-hoc-news.de ·
- Weekly Recap: Q3 revenue falls and VY1706 Alzheimer’s trial screening
TradingView ·
- Voyager Therapeutics, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Voyager Therapeutics, Inc. (VYGR.MX) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Voyager Therapeutics, Inc. (VYGR) options chain
Yahoo Finance UK ·
- Voyager Therapeutics, Inc. (VYGR) Seasonal returns chart
Yahoo Finance UK ·
- Voyager Therapeutics Stock Price Forecast. Should You Buy VYGR?
StockInvest.us ·
- Voyager Therapeutics (NasdaqGS:VYGR) Stock Forecast & Analyst Predictions
Simply Wall St ·
- Voyager Therapeutics Inc earnings beat by $0.02, revenue fell short of estimates
Investing.com UK ·
- Voyager Therapeutics (VYGR) Tops Q3 EPS by 2c
StreetInsider ·
- Voyager Therapeutics (VYGR) Reports Q3 Loss, Lags Revenue Estimates
Yahoo Finance ·
- Voyager Therapeutics: Q3 Earnings Snapshot
Yahoo Finance ·
Voyager Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $40.4M | $80.0M | $250.0M | $40.9M |
| Net income | -$119.7M | -$65.0M | $132.3M | -$46.4M |
| Diluted EPS | $-2.04 | $-1.13 | $2.97 | $-1.21 |
| Total assets (year end) | $252.3M | $393.1M | $351.3M | $159.4M |
| Cash and equivalents (year end) | $65.3M | $71.4M | $68.8M | $99.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Voyager Therapeutics, Inc.
- Ticker
- VYGR (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Lexington, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1640266
Frequently asked questions
What exchange is Voyager Therapeutics, Inc. listed on?
Voyager Therapeutics, Inc. trades on the Nasdaq under the ticker symbol VYGR.
What industry is Voyager Therapeutics, Inc. in?
Voyager Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Voyager Therapeutics, Inc. headquartered?
Voyager Therapeutics, Inc.'s business address on file with the SEC is in Lexington, MA.
When does Voyager Therapeutics, Inc.'s fiscal year end?
Voyager Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Voyager Therapeutics, Inc. report?
Voyager Therapeutics, Inc. reported $40.4M in revenue for calendar year 2025, according to its SEC filings.